Free Trial

Athira Pharma (ATHA) SEC Filings & 10K Form

Athira Pharma logo
$0.64 -0.02 (-3.02%)
(As of 11/22/2024 ET)

Recent Athira Pharma SEC Filings

DateFilerForm TypeView
11/07/2024
12:15 PM
Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G
10/31/2024
3:16 PM
Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
10/28/2024
11:15 PM
Athira Pharma (Filer)
Form EFFECT
10/21/2024
5:24 AM
Athira Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/03/2024
8:50 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4/A
10/03/2024
6:07 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:08 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:10 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:13 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:17 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:05 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
8:00 AM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
6:47 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:48 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:49 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:50 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:51 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:53 PM
Athira Pharma (Subject)
Litton Mark James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:15 PM
Athira Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
6:21 PM
Athira Pharma (Issuer)
Romano Kelly A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:05 PM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
5:54 PM
Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:55 PM
Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:56 PM
Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:58 PM
Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:00 PM
Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:01 PM
Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:03 PM
Athira Pharma (Issuer)
Romano Kelly A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:34 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2024
3:37 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
7:32 AM
Athira Pharma (Filer)
Form DEF 14A
04/09/2024
7:34 AM
Athira Pharma (Filer)
Form DEFA14A
04/09/2024
7:35 AM
Athira Pharma (Filer)
Form ARS
03/28/2024
7:47 AM
Athira Pharma (Filer)
Form PRE 14A
02/22/2024
3:34 PM
Athira Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
3:15 PM
Athira Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
3:46 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:48 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:54 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:32 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4/A
02/16/2024
3:34 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4/A
Former Trump advisor releases terrifying warning (Ad)

Goldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most important financial story of the decade. Goldman Sachs, the IMF, JP Morgan, Bank of America, and Morgan Stanley have issued warnings. Yet most ordinary Americans have no idea. Now one former Trump advisor is sounding the alarm. “If people knew the full facts, there’d be blood in the streets.”

Get the facts and learn how to protect your family now.
02/16/2024
3:37 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4/A
02/16/2024
3:38 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4/A
02/16/2024
3:40 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4/A
01/08/2024
3:36 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:38 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:40 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:42 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:45 PM
Athira Pharma (Issuer)
MOEBIUS HANS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:35 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:11 AM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:24 PM
Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:15 PM
Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ATHA) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners